Skip to main content
Clinical Trials/CTRI/2009/091/000434
CTRI/2009/091/000434
Completed
Phase 3

Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.

Ipca Laboratories Limited0 sites176 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Uncomplicated Plasmodium falciparum malaria
Sponsor
Ipca Laboratories Limited
Enrollment
176
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Male and female patients with age between 18 to 65 years
  • 2\. Patients clinically diagnosed of uncomplicated Plasmodium falciparum malaria with a diagnosis confirmed by positive blood smear with asexual forms of P. falciparum (parasite count between 1000 and 100,000 asexual parasites/µL of blood)
  • 3\. Patients with axillary temperature \>/\= 37\.5 °C and/or history of fever during past 24 hours
  • 4\. Patients with clinical signs and symptoms of malaria
  • 5\. Patients with satisfactory medical assessment with no clinically significant or relevant abnormalities except for study related disease condition.

Exclusion Criteria

  • 1\. Patients with severe malaria as per WHO criteria
  • 2\. Patients with febrile disease other than malaria
  • 3\. Patients with mixed malarial infection
  • 4\. Patients with abnormal heart function including history of QTc prolongation
  • 5\. Patients receiving any concomitant medication which may interact with study drugs
  • 6\. Patients who had taken full course of antimalarials within previous 3 days
  • 7\. Patients with known history of hypersensitivity to any of the study related drugs
  • 8\. Pregnant or lactating women
  • 9\. Women of child bearing potential

Outcomes

Primary Outcomes

Not specified

Similar Trials